[1] ADLER D D, CARSON P L, RUBIN J M, et al. Doppler ultrasound color flow imaging in the study of breast cancer: preliminary findings[J]. Ultrasound Med Biol, 1990,16(6):553-559. [2] FISHER B, BAUER M, WICKERHAM D L, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer[J]. Cancer, 1983,52(9):1551-1557. [3] PENDAS S, DAUWAY E, GIULIANO R,et al. Sentinel node biopsy in ductal carcinoma in situ patients[J]. Ann Surg Oncol,2000,7(1):15-20. [4] de KANTER A Y, van EIJCK C H, van GEEL AN, et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer[J]. Br J Surg,1999,86(11):1459-1462. [5] DRUKKER K, GIGER M, MEINEL L A, et al. Quantitative ultrasound image analysis of axillary lymph node status in breast cancer patients[J]. Int J Comput Assist Radiol Surg, 2013, 8(6): 895-903. [6] KIM T, GIULIANO A E, LYMAN G H. Lymphatic mapping and sentiel lymph node biopsy in early-stage breast carcinoma: a metaanalysis[J]. Cancer, 2006,106(1): 4-16. [7] BARONE J E,TUCKER J B, PEREZ J M, et al. Evidence-based medicine applied to sentiel lymph node biospy in patients with breast cancer[J]. Am Surg,2005,71(1): 66-70. [8] WILKE L G, MCCALL L M, POSTHER K E, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial[J]. Ann Surg Oncol, 2006,13(4):491-500. [9] SAKORAFAS G H, PEROS G, CATALIOTTI L,et al. Lymphedema following axillary lymph node dissection for breast cancer[J]. Surg Oncol,2006,15(3):153-165. [10] BEDI D G, KRISHNAMURTHY R, KRISHNAMURTHY S, et al. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study[J]. AJR Am J Roentgenol, 2008,191(3): 646-652. [11] BRENIN D R, MANASSEH D M, EL-TAMER M, et al. Factors correlating with lymph node metastases in patients with T1 breast cancer[J]. Ann Surg Oncol, 2001,8(5):432-437. [12] 张秀良,常丽英,杨淑贞,等. 594例 Ⅱ、Ⅲ期乳腺癌腋区淋巴结转移相关因素分析[J]. 临床肿瘤学杂志,2003,8(5):26-29. [13] SILVERSTEIN M J, SKIIMER K A, LOMIS T J. Predictting axillary nodal positivity in 2282 patients with breast carcinoma[J]. World J Srug, 2001, 25(6): 767-772. [14] YOSHIHARA E, SMEETS A, LAENEN A, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicabilty in clinical practice[J]. Breast,2013,22(3):357-361. [15] 柳林,陈晰,郭宝良,等. T1期乳腺癌患者腋窝淋巴结转移的相关因素分析[J]. 哈尔滨医科大学学报, 2017,51(4):326-329. [16] AITKEN S J, THOMAS J S, LANGDON S P, et al.Quantitative analysis of changes in ER, PR and HER-2 expression in primary breast cancer and paired nodal metastases[J]. Ann Oncol, 2010, 21(6): 1254-1261. [17] 赵海波,程雪雁,刘金君,等. 乳腺癌原发灶与腋淋巴结转移灶ER和PR及c-cerB-2B表达的对照研究[J]. 中华肿瘤防治杂志,2011,18(8):594-596. [18] 夏红强,何建蓉.Ki-67、EGFR、HER-2和p53在乳腺癌中的表达及其相关性[J]. 临床肿瘤学杂志,2011,16(2):139-143. |